BAUS 2007 GLASGOW
Bankruptcy through biologicals in renal cancer : 27
‘Bottom-up’ costing of minimally invasive treatments for prostate cancer in the NHS : 28
TRUS biopsy training - measuring competence? : 29
The impact of ‘Choose and Book’ on urological outpatient attendance K. CHOW : 30
An audit of the quality of urological intra-operative notes : 31
NICE-improving outcome guidelines for urological cancers : are they achievable?
The international lottery? A rationale for cost analysis in urological practice N. COULL : 33
Changes in department workload and registrar operating experience over a twelve year period : 34
A survey of urological experience amongst general surgery specialist registrars : 35
What is the surgical outcome in men suitable for Active Surveillance? : 36
10 years experience of radical perineal prostatectomy : a joint UK and South African series of 1100 patients
Quality of life outcomes (QOL) post treatment for early localized prostate cancer : a comparison between radical prostatectomy (RRP) and high intensity focused ultrasound (HIFU)
The use of trans-rectal high intensity focused ultrasound in salvage treatment for men who have failed primary radiation therapy of presumed organ confined prostate cancer : 39
3rd generation cryosurgery as salvage treatment for prostate cancer : single centre experience
Do transcriptional repressors of E-cadher-in have a role in bladder cancer? : 41
The function of Fos-related antigen-1 (Fra-1) in transitional cell carcinoma (TCC) of the bladder : 42
Fos-related antigen-1 (Fra-1) - a putative target in muscle-invasive bladder cancer : 43
Down regulation of MT1-MMP leads to inhibition of invasion and increased expression of anti-migratory gene DKK3 in urothelial carcinoma cell line : 44
Hoechst 33342 stem cell identification is a conserved and unified mechanism in urological cancers : 45
Hypospadias surgery in the developing world : 10 years, 600 cases
Urethroplasty is a 23 hour stay procedure : 47
The outcome of single and two stage buccal graft reconstruction for glanular urethral strictures : 48
Total phallic construction using the forearm free flap : 49
Long-term bowel dysfunction after transposition of intestinal segments into the urinary tract : 50
Urolithiasis and enterocystoplasty - the role of biochemical and dietary factors : 51
Mechanism of lower urinary tract injury in pelvic fractures : 52
Open partial nephrectomy : a series of 141 patients
Open partial nephrectomy : the experience of one South London centre
Laparoscopically assisted renal cryoablation for small renal tumours≃ results from a European multicentre study : 82
Comparison of laparoscopic versus open nephroureterectomy in the treatment of upper tract transitional cell cancer : 83
Avoiding major renal surgery for benign lesions - exploring the potential of immunohistochemistry : 84
Management of angiomyolipoma (AML) in a single centre : 85
Muscarinic acetylcholine receptor M1 (M1AChR) in the urothelium and suburothelium of normal and overactive human bladder : preliminary immunohistochemical data
The effect of b-adrenoceptor agonists and b3-adrenoceptor antagonist on detrusor contraction in the presence and absence of urothelium : 87
The effect of interferon-gamma on urothelial barrier function : 88
Cholinergic control of prostate contractility mediated through smooth muscle M3 receptors : 89
Dynamic changes in regional brain activity with sacral nerve stimulation in Fowler's syndrome : 90
What is the contemporary standard for morbidity and outcome for radical pelvic surgery in the UK? : 91
Estimated GFR as a predictor of morbidity following radical cystectomy : 92
Rapid recovery surgery : the role of early enteral feeding to improve surgical outcome following radical cystectomy for invasive bladder cancer
Troponin I elevation may predict silent myocardial ischaemia during radical cystectomy for muscle invasive bladder cancer : 94
Lymphovascular invasion in bladder cancer : is it an important prognostic indicator?
96
Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder : 97
Comparison of treatment outcome for radical surgery versus radical radiotherapy for invasive bladder cancer treated in a UK specialist treatment centre : 98
Intravesical BCG and superficial bladder cancer. Outcome of 100 consecutive patients with 5–15 years follow up : P01
The tolerability of two BCG maintenance regimes in the treatment of high-risk superficial bladder cancer (HRSBC) : P02
Can Invitro Cytoimmunoassay individualise adjuvant intravesical therapy for superficial bladder cancer : P03
An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer : P04
Clinical understaging of muscle invasive bladder cancer : P05
Rates of cystectomy in superficial bladder cancer patients in the UK : P06
Paediatric bladder stone disease : a study of nutritional factors predisposing to its cause.
ncidence and management of bladder stones in patients with long-term urinary catheters : The Catheter Research Clinic
7 mm. is an appropriate cut off for treatment of distal ureteric stones by single session in situ extracorporeal shock wave lithotripsy : P09
In vitro evaluation of the StoneBreaker™ : a novel cordless pneumatic lithotripter
A systematic review of studies reporting complications of upper urinary tract stone ablation using the Holmium : YAG laser
Rapid de-blocking of ureteric stones with extracorporeal shockwave lithotripsy (SWL) is cost effective! : P12
The development of an algorithm from measurements in non-contrast computerized tomograms to improve selection of upper ureteric stone for shock wave lithotripsy : P13
A retrograde approach is an effective management option for large renal calculi : P14
Role of inflammatory markers as an aid to emergency management of the obstructed kidney : P15
The role of urine cytology in the initial assessment of patients with haematuria : P16
Urine cytology in the investigation of haematuria - Is it really worth it? : P17
CT urogram as an initial investigation for frank haematuria : P18
Narrow band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder : P19
Does Fluorescence enhanced Cystoscopy (FC) and transurethral resection of bladder cancer improve accuracy and as a result patient care? : P20
Hexylaminolevulinate Photodynamic Diagnosis (HPD) following intravesical Bacille Calmette Guerin (BCG) for superficial bladder cancer : P21
Hexylaminolevulinate photodynamic assisted cystoscopy in the investigation of clinically unconfirmed positive urine cytology : P22
Ultimate urology : taking one stop, one step further
Microscopic haematuria - do urologists follow the CKD guidelines? : P24
A new supra-regional penile cancer service employing an urgent fax/e-mail response system and regular multidisciplinary (MDT) meetings via teleconferencing : P25
Patient's satisfaction following transfer of care from a District General Hospital (DGH) to its designated cancer centre : P26
Follow-up of stable prostate cancer patients-a novel approach : P27
Emergency (on-call) urological services : can the core urologist provide effective and competent cover?
The cost ineffectiveness of specialist nurses in the diagnosis of incontinence : P29
‘Hospital at Home’ - a service to reduce hospital stay : P30
A simple well validated method for measuring urinary urgency : P31
10-year experience of sacral neuromodu-lation in urinary retention - results from UK tertiary referral centre : P32
Randomised controlled study of cannabis based medicine (CBM, Sativex®) in patients suffering from multiple sclerosis associated detrusor overactivity : P33
Intradetrusor injection of botulinum neurotoxin type A (BoNT/A) in the treatment of detrusor overactivity : results of repeat injections
Analysis of voiding dysfunction following botulinum toxin-A treatment for overac-tive bladder : P35
Is patient history of stress urinary incontinence (SUI) a reliable predictor of urodynamic stress incontinence (USI) in women? : P36
Evaluation of sexual function in women with stress urinary incontinence using the Abbreviated Sexual Function Questionnaire (ASFQ) : P37
The outcome of the Mitrofanoff procedure in neurogenic and non-neurogenic voiding dysfunction : P38
Development of a minimally invasive investigation algorithm for the urological management of patients with spina bifida : P39
The tumour-stroma distribution of degradome components in human prostate cancer : P40
Malondialdehyde-deoxyguanosine (M1G) is a biomarker of prostate cancer chemoprevention by tea polyphenols in the TRAMP mouse : P41
Synergistic enhancement of prostate cancer cell death by combination therapy of adenovirus and chemotherapy : P42
The fibroblast growth factor receptor inhibitor PD01 73074 as a potential novel anti-prostate cancer therapy : P43
Stain-free biochemical imaging of the prostate utilising FTIR microspectroscopy : a proof of concept study
The complete cytokeratin phenotype of the human prostate and changes associated with malignant disease : P45
Real-time PCR (rtPCR) validation of the differential microarray profile of the prostate epithelial cell side population : P46
Serum bone markers to predict disease progression in prostate cancer - a comparative performance analysis : P47
Epigallocatechin-3-gallate and lycopene have a more potent effect on prostate cancer cells than casodex in the presence of dihydrotestosterone : P48
Expression of gonadotrophin releasing hormone type II in prostate cancer is androgen regulated : P49
Antegrade vs retrograde stenting in laparoscopic pyeloplasty : P50
Survival after nephrostomy for malignant renal obstruction : P51
An audit of long term follow-up of antegrade ureteric stenting as a procedure of choice for the management of obstructive uropathy in pelvic malignancies : P52
One stage tubeless antegrade ureteric stenting : a safe and cost effective option
Ureteric obstruction following renal transplantion : open surgical treatment is associated with better outcome than minimally invasive techniques
The prevalence of renal impairment following nephrectomy : P55
Transureteric ultrasonography can be a useful radiological technique in the investigation of ureteric stricture : P56
An abdominal phantom for the evaluation of three-dimensional ultrasound and guided interventional techniques in the kidney : P57
Multidetector CT Urography (MDCTU) for diagnosing urothelial tumour of the upper urinary tract : P58
Laparoscopic Partial Nephrectomy (LPN) : 50 consecutive cases from a UK centre
Laparoscopic Partial Nephrectomy (LPN) - initial experience of a BUF preceptor : P60
A novel laparoscopically-deployed device for renal hypothermia : cooling efficacy in a porcine model
Robot-assisted radical cystectomy for bladder cancer and 2 year follow-up : P62
A comparative study of 100 Robot Assisted Laparoscopic Prostatectomy (RALP) versus 100 open Retropubic Prostatectomy (RP) : P63
The learning curve for robotic prostatectomy in a UK healthcare setting : P64
Learning curve during robotic-assisted radical prostatectomy : P65
A comparison of post operative inguinal hernia rates after laparoscopic, retropubic and perineal radical prostatectomy : P66
The risk of prostate cancer amongst black men in the United Kingdom : P67
Long term follow-up of men with elevated PSA levels : a population-based study
The utility of PSA velocity thresholds in clinical practice : a population-based analysis
The Charlson score should replace simple age and subjective comorbidity judgement in our prostate cancer MDT : P70
Pre operative prostate magnetic resonance imaging at 3.0 Tesla, hope or hype! : P71
Is it safe to perform nerve sparing surgery during radical prostatectomy on the side of the prostate negative for cancer on TRUS biopsy? : P72
Frequency of zoledronic acid to prevent bone loss in osteoporotic patients requiring androgen-deprivation therapy for prostate cancer : P73
Auricular acupuncture - an alternative treatment for vasomotor symptoms associated with LHRH analogue treatment : P74
Audit of an approach to Post-Vasectomy Semen Analysis (PVSA) - reliability, cost-effectiveness and feasibility of application to a nurse-led service. : P75
Fluorescent viability testing of human sperm - a novel technique to establish vasectomy success in early post-vasectomy recanalisation : P76
The genetic analysis of sperm in the subfertile male : a predictor of clinical outcome?
Microdissection Testicular Exploration and Sperm Extraction (Micro-TESE) -sperm retrieval rates in Sertoli Cell Only : P78
The isolated testis biopsy reborn : P79
Management of unexpected positive margins in penile reconstructive surgery : P80
Surgical management of lymphoedema of the genitalia : P81
Penile prosthesis insertion in acute ischaemic priapism : long term follow-up
Circumcision is not mandatory in penile surgery : P83
Can prostatic area be used to diagnose bladder outlet obstruction (BOO) in those who fail to void at the time of urodynamics? : P84
The failure of cystometric pressure/flow plots in characterising bladder outflow obstruction : P85
Can a computer kick the urologist out of the office? : P86
The long term outcome of men who successfully trial without catheter with alpha blocker during acute retention of urine : P87
Acute urinary retention is associated with an increased risk of mortality : P88
Holmium Laser Enucleation of the Prostate (HoLEP) : does size matter?
Experience with green light laser prostatectomy at a UK district general hospital : P90
Cost-effectiveness of single and multiple treatment strategies for surgical management of benign prostatic enlargement : P91
Role of alpha blockers in improving recovery following TURP - a prospective, randomised controlled trial : P92
The over-prescription of antibiotics following TURP : P93
Hypoxia-Inducible Factor-1α expression is increased in the tunica albuginea of men with Peyronie's disease-hypoxia is an aetiological factor? : U01
Propionibacterium acnes : prostate inflammation and prostate cancer
The unique use of ammonium ion-selective electrodes in renal staghorn research and the validation of this technique : U03
The expression of Tight Junction proteins Claudins 11 and 15 in normal human urothelium and transitional cell carcinoma : U04
Objective measurement of invasive spindle cell morphology in AY-27 bladder cancer cells : U05
Isolation and characterisation of a stem cell enriched side-population from bladder urothelium : U06
The effect of NCX1102, a nitric oxide-donating derivative of sulindac, on prostate cancer cells under hypoxia : U07
Antibody immunity to prostate cancer specific antigen in the serum of patients having cryotherapy or brachytherapy treatment compared to healthy volunteers : U08
Nifedipine protects against contractile failure in a model of ischaemic priapism : U09
The effect of the urothelium on the spontaneous activity of the mouse detrusor smooth muscle : U10
Effect of citrate on urinary catheter biofilm development due to urease producing organisms : U11
Genitourinary cancers following renal transplantation : U12
Salvage orchidectomy may not always be required in patients undergoing primary chemotherapy for metastatic germ cell tumour of the testis : U13
Defining the limits. Preoperative marking of the resection limit in TURP : U14
Following EAU guidelines for inguinal lymphadenectomy for penile carcinoma; does it reduce the numbers of negative dissections? : U15
Buried penis : a simple method for surgical repair
A one stop multidisciplinary clinic for Von Hippel-Lindau disease : U17
Mucocutaneous contamination is a significant risk in endo-urology : U18
Evidence against the validity of nitrite testing for urinary tract infection : U19
The urological cancer observatory project : U20
High Intensity Focused Ultrasound (HIFU) as a salvage treatment for recurrent prostate cancer after brachytherapy -a feasibility study : U21
Testicular microlithiasis : prevalence and risk of concurrent and interval development of testicular tumour in a referred population